ST. JUDE MEDICAL® Valve Replacement in Infants and Children

  • A. Michael Borkon
  • Bruce A. Reitz
  • James S. Donahoo
  • Timothy J. Gardner

Abstract

Cardiac valve replacement with ST. JUDE MEDICAL® valves was undertaken in 27 infants and children ages 3 weeks to 17 years, with an average age of 9 years. Valve implant sites were 12 aortic, 14 mitral and 1 pulmonic. Six aortic valve replacements were with 19 mm aortic valves; only 1 required anulus enlargement. Due to the small size of the mitral anulus, a 19 mm aortic valve was used in 3 children. Follow-up was 100% for a mean of 2.3 years per patient. Seven children (5 mitral and 2 aortic) took aspirin for anticoagulation with 1 valve thrombosis and 2 deaths. The number of children over age 5 taking warfarin was 18 with 1 emboli, 1 hemorrhage, no valve thrombosis and 1 death. The number of patients event-free at 5 years was 76%.

Keywords

Pneumonia Aspirin Dehydration Warfarin Cardiomyopathy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gardner TJ, Roland JMA, Neill CA, Donahoo JD: Valve replacement in children. A fifteen year perspective. J Thorac Cardiovasc Surg 1982; 83: 178–185.PubMedGoogle Scholar
  2. 2.
    Dunn JM: Porcine valve durability in children. Ann Thorac Surg 1981; 32: 357–368.PubMedCrossRefGoogle Scholar
  3. 3.
    Donahoo JS and Gardner TJ: Early and intermediate experience with the St. Jude mechanical cardiac valve prosthesis in infants and children. Southern Medical Journal 1982; 75: 1538–1543.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • A. Michael Borkon
  • Bruce A. Reitz
  • James S. Donahoo
  • Timothy J. Gardner

There are no affiliations available

Personalised recommendations